Therefore, we have selected nine genes differentially modulated between the intestinal and diffuse gastric cancer samples: FPR2, CARD14, CXCR2, EFNA2, CXCR1, AQP9, TRIP13, GHRL and KLK11, to be used as differentially expressed biomarkers for gastric cancers. The gene discussed is CXCR1; the disease is gastric cancer.